TABLE 1A.
Patient population characteristics for the entire study.
| NP-SLE patients (n = 43) | non-NPSLE patients (n = 120) | |
| Female, n (%) | 37 (86%) | 110 (92%) |
| Age, years | 40 ± 13 | 42 ± 13 |
| NPSLE phenotypes | ||
| Inflammatory | 30 (70%) | – |
| Ischemic | 13 (30%) | – |
| Hypertension | 16 (37%) | 35 (30%) |
| Current smoking | 12 (28%) | 34 (28%) |
| BMI | 25 ± 6 | 25 ± 4 |
| Diabetes | 3 (7%) | 6 (5%) |
| Duration of SLE, years | 6 ± 8 | 8 ± 8 |
| SLEDAI-2K | 8 ± 5 | 4 ± 4 |
| SDI | 1.5 ± 1.2 | 0.9 ± 1.1 |
Sex, age and SLE clinical variables are described for the population included in the study. SLEDAI = Systemic Lupus Erythematosus Disease Activity Index 2000. SDI = Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index.